DEF 14AThe Ballot
Theriva Biologics, Inc. files DEF 14A
Filed Aug 16, 2022 · 3y ago · Accession 0001104659-22-091820
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Theriva Biologics, Inc.
- Ticker
- TOVX
- CIK
- 894158
- Form type
- DEF 14A
- Filing date
- Aug 16, 2022
- Report date
- Sep 30, 2022
- Document
- tm2222180-2_def14a.htm
- Size
- 2.7 MB